[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100648512":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":32,"locations":32,"responsibleParty":33,"collaborators":32,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":32,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":32,"enrollmentInfo":46,"targetDuration":32,"studyType":49,"phases":50,"briefSummary":52,"conditions":53,"keywords":32,"overallStatus":58,"whyStopped":32,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":32},{"fullName":5,"class":6},"Khyber Teaching Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"High-Flow Nasal Cannula (HFNC)","EXPERIMENTAL","Participants randomized to this arm will receive preoxygenation using a heated, humidified high-flow nasal cannula delivering oxygen at 60 L\u002Fmin with an FiO₂ of 100% for 3 minutes before rapid sequence induction. The HFNC will remain in place during induction and laryngoscopy until successful endotracheal intubation to provide continuous oxygenation throughout the apneic period.",[13],"Device: High-Flow Nasal Cannula",{"label":15,"type":16,"description":17,"interventionNames":18},"Tight Face Mask (TFM)","ACTIVE_COMPARATOR","Participants randomized to this arm will receive standard preoxygenation using a tightly fitting anesthesia face mask delivering 100% oxygen at 15 L\u002Fmin for 3 minutes before rapid sequence induction. The face mask will be removed immediately before laryngoscopy according to routine clinical practice.\n\nThese arm titles and descriptions are appropriate for ClinicalTrials.gov registration. The next step will be to link each arm to its corresponding Device Intervention (HFNC and Tight Face Mask).",[19],"Device: Tight Face Mask",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","High-Flow Nasal Cannula","Participants assigned to this intervention will receive preoxygenation using a heated, humidified high-flow nasal cannula delivering oxygen at a flow rate of 60 L\u002Fmin with an inspired oxygen fraction (FiO₂) of 1.0 (100%) for 3 minutes before rapid sequence induction. Oxygen delivery will be continued throughout the apneic period and laryngoscopy until successful endotracheal intubation.",[9],[27],"High-Flow Nasal Oxygen (HFNO)",{"type":22,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"Tight Face Mask","Participants assigned to this intervention will receive standard preoxygenation using a tightly fitting anesthesia face mask delivering 100% oxygen at a flow rate of 15 L\u002Fmin for 3 minutes before rapid sequence induction. The face mask will be removed immediately before laryngoscopy in accordance with standard clinical practice.",[15],null,{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"PRINCIPAL_INVESTIGATOR","Shandana Gul","Post Graduate Resident","100648512","comparison-of-high-flow-nasal-cannula-and-tight-face-mask-for-maintaining-oxygenation-during-rapid-sequence-induction-100648512",false,"NCT07723430","Comparison of High-Flow Nasal Cannula and Tight Face Mask for Maintaining Oxygenation During Rapid Sequence Induction","Comparison of the Effectiveness of High-Flow Oxygen Cannula Versus Tight Face Mask in Maintaining Oxygenation During Rapid Sequence Induction","Inclusion Criteria:\n\n* Adults aged 18 years or older.\n* Patients requiring rapid sequence induction (RSI) for endotracheal intubation in the operating room, emergency department, or intensive care unit.\n* Patients in whom both high-flow nasal cannula (HFNC) and tight face mask preoxygenation are technically feasible.\n* Patients (or their legally authorized representatives, when applicable) able to provide written informed consent.\n\nExclusion Criteria:\n\n* Patients requiring immediate crash intubation without sufficient time for preoxygenation.\n* Patients with facial deformities, upper airway obstruction, or other conditions preventing the use of either HFNC or a tight face mask.\n* Known contraindications or hypersensitivity to medications used for rapid sequence induction.\n* Pregnant women.\n* Patients younger than 18 years of age.\n* Patients with do-not-intubate (DNI) orders.\n* Patients already intubated or mechanically ventilated before enrollment.\n* Patients who underwent endotracheal intubation within the previous 24 hours.","ALL","18 Years",{"count":47,"type":48},290,"ESTIMATED","INTERVENTIONAL",[51],"NA","This prospective randomized controlled trial aims to compare the effectiveness of High-Flow Nasal Cannula (HFNC) versus Tight Face Mask (TFM) in maintaining oxygenation during rapid sequence induction (RSI) for endotracheal intubation in adult patients. Participants will be randomly assigned in a 1:1 ratio to receive either HFNC or TFM for preoxygenation before induction of anesthesia. The primary outcome is the lowest peripheral oxygen saturation (SpO₂) recorded from induction until successful endotracheal intubation. Secondary outcomes include the incidence of oxygen desaturation (\\\u003C90%), duration of apnea, duration of laryngoscopy, intubation time, number of intubation attempts, and peri-intubation complications. The study will determine whether HFNC provides superior oxygenation compared with conventional face mask preoxygenation during RSI and may contribute to improving airway management protocols and patient safety.",[54,55,56,57],"Hypoxemia","Airway Management","Endotracheal Intubation","Rapid Sequence Induction","NOT_YET_RECRUITING","2026-07-22",{"date":61,"type":62},"2026-07-23","ACTUAL",{"date":64,"type":48},"2026-08-01",{"date":66,"type":48},"2027-02-20",{"name":5,"class":6}]